CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations · Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $12.62 ($63,100)
- 8-K Event Regulation FD disclosure · Other events
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Chief Executive Officer bought 15,000 shares at $14.89 ($223,350)
- 8-K Event Auditor change
- ARS Other Annual Report to Security Holders
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 76 · 1,519 filings